Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
34
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Murphy Christopher M. | Chief Financial & Bus. Officer | 5 | $0 | $0 | 2025-08-11 |
| Seidel Hans Martin | Director | 9 | $0 | $0 | 2025-08-11 |
| Gladstone Michael | Director, 10% Owner | 6 | $0 | $0 | 2025-08-11 |
| Holles Natalie C. | CEO | 19 | $0 | $411.6K | 2025-08-11 |
| Bonita David P | Director, 10% Owner | 12 | $5.10M | $0 | 2025-08-11 |
| Soloway Thomas P | Director | 8 | $0 | $0 | 2025-08-11 |
| Iwicki Mark T | Director | 9 | $0 | $0 | 2025-08-11 |
| Dean Dennis | Chief Nonclinical Dev. Officer | 3 | $0 | $0 | 2025-01-15 |
| Dittman Jennifer | Chief Operating Officer | 14 | $0 | $352.6K | 2025-01-15 |
| Person Julie | Chief Administrative Officer | 24 | $0 | $410.9K | 2025-01-15 |
| Dinsmore Christopher | Chief Scientific Officer | 4 | $0 | $0 | 2025-01-15 |
| Conner Edward R. | Chief Medical Officer | 21 | $0 | $191.7K | 2025-01-15 |
| Atlas Venture Fund XI, L.P. | 10% Owner | 1 | $0 | $0 | 2024-11-01 |
| BVF INC/IL | Other | 3 | $0 | $14.30M | 2024-10-29 |
| MCDONOUGH GEOFF | Director | 1 | $0 | $0 | 2024-03-27 |
| Ray Adrian S. | Chief Scientific Officer | 7 | $0 | $0 | 2023-03-06 |
| Ho Robert | Chief Financial Officer | 6 | $0 | $0 | 2023-03-06 |
| PEREZ ROBERT J | Director | 3 | $0 | $0 | 2023-03-06 |
| BIOTECHNOLOGY VALUE FUND II LP | Other | 3 | $879.8K | $0 | 2022-12-20 |
| Lin Shao-Lee | Director | 1 | $0 | $0 | 2022-10-26 |
| Atlas Venture Associates XI, LLC | 10% Owner | 7 | $5.10M | $0 | 2022-09-19 |
| OrbiMed Capital GP VII LLC | Director, 10% Owner | 5 | $5.10M | $0 | 2022-09-19 |
| STEWART DENNIS ROBERT | EVP/CFO | 3 | $0 | $0 | 2014-09-16 |
| LUFKIN KENT C | President and CEO | 4 | $0 | $0 | 2014-09-11 |
| POLLACK DENNIS | Director | 24 | $89.5K | $0 | 2014-04-01 |
| TANTALA ALBERT M | Director | 28 | $91.1K | $0 | 2014-04-01 |
| DUSEK ROBERT N | Other | 26 | $67.2K | $0 | 2014-04-01 |
| GREGORY CARL F | Director | 16 | $0 | $0 | 2014-04-01 |
| SWANSTROM KENNETH A | Director | 16 | $0 | $0 | 2014-04-01 |
| KASPERN ELIZABETH A | EVP | 2 | $0 | $0 | 2014-01-24 |
| PERKINS H DONALD JR | Director | 16 | $125.6K | $0 | 2013-10-01 |
| Slabinski Joseph F III | Director | 16 | $7.6K | $0 | 2013-10-01 |
| Wood James B | Director | 12 | $0 | $0 | 2013-10-01 |
| STRANFORD JOHN R | Director | 9 | $0 | $98.0K | 2012-10-01 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Bonita David P | Director | J Other deriv | 2025-08-11 | 2025-08-14 | 43,584 | — | $0 | 0 | SEC↗ |
| Soloway Thomas P | Director | J Other deriv | 2025-08-11 | 2025-08-14 | 120,166 | — | $0 | 0 | SEC↗ |
| Seidel Hans Martin | Director | J Other deriv | 2025-08-11 | 2025-08-14 | 53,090 | — | $0 | 0 | SEC↗ |
| Iwicki Mark T | Director | J Other deriv | 2025-08-11 | 2025-08-14 | 83,296 | — | $0 | 0 | SEC↗ |
| Murphy Christopher M. | Chief Financial & Bus. Offic | J Other deriv | 2025-08-11 | 2025-08-14 | 47,500 | — | $0 | 0 | SEC↗ |
| Gladstone Michael | Director, 10% Owner | J Other deriv | 2025-08-11 | 2025-08-14 | 43,584 | — | $0 | 0 | SEC↗ |
| Holles Natalie C. | CEO | J Other deriv | 2025-08-11 | 2025-08-14 | 50,000 | — | $0 | 0 | SEC↗ |
| Holles Natalie C. | CEO | J Other deriv | 2025-08-11 | 2025-08-14 | 998,854 | — | $0 | 0 | SEC↗ |
| Bonita David P | Director | J Other | 2025-08-11 | 2025-08-14 | 5,779,071 | — | $0 | 0 | SEC↗ |
| Seidel Hans Martin | Director | J Other | 2025-08-11 | 2025-08-14 | 85,753 | — | $0 | 0 | SEC↗ |
| Iwicki Mark T | Director | J Other | 2025-08-11 | 2025-08-14 | 128,631 | — | $0 | 0 | SEC↗ |
| Holles Natalie C. | CEO | J Other | 2025-08-11 | 2025-08-14 | 1,218,836 | — | $0 | 0 | SEC↗ |
| Murphy Christopher M. | Chief Financial & Bus. Offic | A Award deriv | 2025-03-01 | 2025-03-05 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Holles Natalie C. | CEO | A Award deriv | 2025-01-15 | 2025-01-17 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Holles Natalie C. | CEO | A Award deriv | 2025-01-15 | 2025-01-17 | 400,000 | — | $0 | 400,000 | SEC↗ |
| Dean Dennis | Chief Nonclinical Dev. Offic | A Award deriv | 2025-01-15 | 2025-01-17 | 11,500 | — | $0 | 11,500 | SEC↗ |
| Dean Dennis | Chief Nonclinical Dev. Offic | A Award deriv | 2025-01-15 | 2025-01-17 | 92,000 | — | $0 | 92,000 | SEC↗ |
| Dinsmore Christopher | Chief Scientific Officer | A Award deriv | 2025-01-15 | 2025-01-17 | 14,500 | — | $0 | 14,500 | SEC↗ |
| Dinsmore Christopher | Chief Scientific Officer | A Award deriv | 2025-01-15 | 2025-01-17 | 116,000 | — | $0 | 116,000 | SEC↗ |
| Person Julie | CHIEF ADMINISTRATIVE OFFICER | A Award deriv | 2025-01-15 | 2025-01-17 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Person Julie | CHIEF ADMINISTRATIVE OFFICER | A Award deriv | 2025-01-15 | 2025-01-17 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Conner Edward R. | Chief Medical Officer | A Award deriv | 2025-01-15 | 2025-01-17 | 16,500 | — | $0 | 16,500 | SEC↗ |
| Conner Edward R. | Chief Medical Officer | A Award deriv | 2025-01-15 | 2025-01-17 | 132,000 | — | $0 | 132,000 | SEC↗ |
| Dittman Jennifer | Chief Operating Officer | A Award deriv | 2025-01-15 | 2025-01-17 | 92,000 | — | $0 | 92,000 | SEC↗ |
| Dittman Jennifer | Chief Operating Officer | A Award deriv | 2025-01-15 | 2025-01-17 | 11,500 | — | $0 | 11,500 | SEC↗ |
| Murphy Christopher M. | Chief Financial & Bus. Offic | A Award deriv | 2025-01-15 | 2025-01-17 | 17,500 | — | $0 | 17,500 | SEC↗ |
| Murphy Christopher M. | Chief Financial & Bus. Offic | A Award deriv | 2025-01-15 | 2025-01-17 | 140,000 | — | $0 | 140,000 | SEC↗ |
| Conner Edward R. | Chief Medical Officer | M Exercise deriv | 2024-11-08 | 2024-11-12 | 2,117 | — | $0 | 368,918 | SEC↗ |
| Conner Edward R. | Chief Medical Officer | M Exercise | 2024-11-08 | 2024-11-12 | 2,117 | $4.20 | $8.9K | 2,117 | SEC↗ |
| Conner Edward R. | Chief Medical Officer | S Sale | 2024-11-08 | 2024-11-12 | 2,117 | $15.00 | $31.8K | 0 | SEC↗ |
| Atlas Venture Fund XI, L.P. | 10% Owner | J Other | 2024-11-01 | 2024-11-05 | 515,688 | — | $0 | 9,798,075 | SEC↗ |
| BVF INC/IL | Other | S Sale | 2024-10-29 | 2024-10-31 | 396,963 | $14.30 | $5.68M | 1,367,257 | SEC↗ |
| BVF INC/IL | Other | S Sale | 2024-10-29 | 2024-10-31 | 538,420 | $14.30 | $7.70M | 1,794,218 | SEC↗ |
| BVF INC/IL | Other | S Sale | 2024-10-29 | 2024-10-31 | 64,617 | $14.30 | $924.0K | 176,692 | SEC↗ |
| Conner Edward R. | Chief Medical Officer | M Exercise deriv | 2024-10-28 | 2024-10-30 | 2,673 | — | $0 | 371,035 | SEC↗ |
| Conner Edward R. | Chief Medical Officer | M Exercise | 2024-10-28 | 2024-10-30 | 2,673 | $4.20 | $11.2K | 2,673 | SEC↗ |
| Conner Edward R. | Chief Medical Officer | S Sale | 2024-10-28 | 2024-10-30 | 2,673 | $15.00 | $40.1K | 0 | SEC↗ |
| Person Julie | CHIEF ADMINISTRATIVE OFFICER | M Exercise deriv | 2024-09-19 | 2024-09-20 | 9,497 | — | $0 | 155,962 | SEC↗ |
| Conner Edward R. | Chief Medical Officer | M Exercise deriv | 2024-09-19 | 2024-09-20 | 4,790 | — | $0 | 373,708 | SEC↗ |
| Person Julie | CHIEF ADMINISTRATIVE OFFICER | S Sale | 2024-09-19 | 2024-09-20 | 9,497 | $14.29 | $135.7K | 0 | SEC↗ |
| Person Julie | CHIEF ADMINISTRATIVE OFFICER | M Exercise | 2024-09-19 | 2024-09-20 | 9,497 | $4.20 | $39.9K | 9,497 | SEC↗ |
| Conner Edward R. | Chief Medical Officer | S Sale | 2024-09-19 | 2024-09-20 | 4,790 | $15.00 | $71.8K | 0 | SEC↗ |
| Conner Edward R. | Chief Medical Officer | M Exercise | 2024-09-19 | 2024-09-20 | 4,790 | $4.20 | $20.1K | 4,790 | SEC↗ |
| Person Julie | CHIEF ADMINISTRATIVE OFFICER | M Exercise deriv | 2024-09-18 | 2024-09-20 | 503 | — | $0 | 165,459 | SEC↗ |
| Person Julie | CHIEF ADMINISTRATIVE OFFICER | S Sale | 2024-09-18 | 2024-09-20 | 503 | $14.00 | $7.0K | 0 | SEC↗ |
| Person Julie | CHIEF ADMINISTRATIVE OFFICER | M Exercise | 2024-09-18 | 2024-09-20 | 503 | $4.20 | $2.1K | 503 | SEC↗ |
| Person Julie | CHIEF ADMINISTRATIVE OFFICER | M Exercise deriv | 2024-06-26 | 2024-06-28 | 10,000 | — | $0 | 165,962 | SEC↗ |
| Person Julie | CHIEF ADMINISTRATIVE OFFICER | M Exercise | 2024-06-26 | 2024-06-28 | 10,000 | $4.20 | $42.0K | 10,000 | SEC↗ |
| Person Julie | CHIEF ADMINISTRATIVE OFFICER | S Sale | 2024-06-26 | 2024-06-28 | 10,000 | $12.46 | $124.6K | 0 | SEC↗ |
| Dittman Jennifer | Chief Development Oper Offic | M Exercise deriv | 2024-06-07 | 2024-06-10 | 494 | — | $0 | 16,294 | SEC↗ |
| Dittman Jennifer | Chief Development Oper Offic | S Sale | 2024-06-07 | 2024-06-10 | 494 | $14.17 | $7.0K | 0 | SEC↗ |
| Dittman Jennifer | Chief Development Oper Offic | A Award | 2024-06-07 | 2024-06-10 | 494 | $4.20 | $2.1K | 494 | SEC↗ |
| Bonita David P | Director | A Award deriv | 2024-06-06 | 2024-06-10 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Gladstone Michael | Director, 10% Owner | A Award deriv | 2024-06-06 | 2024-06-10 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Soloway Thomas P | Director | A Award deriv | 2024-06-06 | 2024-06-10 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Seidel Hans Martin | Director | A Award deriv | 2024-06-06 | 2024-06-10 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Iwicki Mark T | Director | A Award deriv | 2024-06-06 | 2024-06-10 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Dittman Jennifer | Chief Development Oper Offic | M Exercise deriv | 2024-05-20 | 2024-05-22 | 1,042 | — | $0 | 32,292 | SEC↗ |
| Dittman Jennifer | Chief Development Oper Offic | S Sale | 2024-05-20 | 2024-05-22 | 1,042 | $14.00 | $14.6K | 0 | SEC↗ |
| Dittman Jennifer | Chief Development Oper Offic | A Award | 2024-05-20 | 2024-05-22 | 1,042 | $4.30 | $4.5K | 1,042 | SEC↗ |
| Dean Dennis | Chief Nonclinical Dev. Offic | A Award deriv | 2024-05-16 | 2024-05-20 | 210,000 | — | $0 | 210,000 | SEC↗ |
| Dittman Jennifer | Chief Development Oper Offic | M Exercise deriv | 2024-05-16 | 2024-05-20 | 6,912 | — | $0 | 16,788 | SEC↗ |
| Dittman Jennifer | Chief Development Oper Offic | M Exercise deriv | 2024-05-16 | 2024-05-20 | 16,666 | — | $0 | 33,334 | SEC↗ |
| Dittman Jennifer | Chief Development Oper Offic | A Award deriv | 2024-05-16 | 2024-05-20 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Dinsmore Christopher | Chief Scientific Officer | A Award deriv | 2024-05-16 | 2024-05-20 | 210,000 | — | $0 | 210,000 | SEC↗ |
| Dinsmore Christopher | Chief Scientific Officer | A Award deriv | 2024-05-16 | 2024-06-28 | 297,000 | — | $0 | 297,000 | SEC↗ |
| Dittman Jennifer | Chief Development Oper Offic | A Award | 2024-05-16 | 2024-05-20 | 6,912 | $4.20 | $29.0K | 23,578 | SEC↗ |
| Dittman Jennifer | Chief Development Oper Offic | S Sale | 2024-05-16 | 2024-05-20 | 23,578 | $14.04 | $331.0K | 0 | SEC↗ |
| Dittman Jennifer | Chief Development Oper Offic | A Award | 2024-05-16 | 2024-05-20 | 16,666 | $4.30 | $71.7K | 16,666 | SEC↗ |
| Holles Natalie C. | CEO | M Exercise deriv | 2024-05-09 | 2024-05-10 | 20,222 | — | $0 | 433,854 | SEC↗ |
| Holles Natalie C. | CEO | S Sale | 2024-05-09 | 2024-05-10 | 20,222 | $12.18 | $246.3K | 1,218,836 | SEC↗ |
| Holles Natalie C. | CEO | M Exercise | 2024-05-09 | 2024-05-10 | 20,222 | $4.20 | $84.9K | 1,239,058 | SEC↗ |
| Holles Natalie C. | CEO | M Exercise deriv | 2024-04-11 | 2024-04-15 | 13,558 | — | $0 | 454,076 | SEC↗ |
| Holles Natalie C. | CEO | M Exercise | 2024-04-11 | 2024-04-15 | 13,558 | $4.20 | $56.9K | 1,232,394 | SEC↗ |
| Holles Natalie C. | CEO | S Sale | 2024-04-11 | 2024-04-15 | 13,558 | $12.19 | $165.3K | 1,218,836 | SEC↗ |
| Person Julie | CHIEF ADMINISTRATIVE OFFICER | M Exercise deriv | 2024-04-04 | 2024-04-08 | 1,107 | — | $0 | 175,962 | SEC↗ |
| Person Julie | CHIEF ADMINISTRATIVE OFFICER | M Exercise | 2024-04-04 | 2024-04-08 | 1,107 | $4.20 | $4.6K | 1,107 | SEC↗ |
| Person Julie | CHIEF ADMINISTRATIVE OFFICER | S Sale | 2024-04-04 | 2024-04-08 | 1,107 | $10.00 | $11.1K | 0 | SEC↗ |
| MCDONOUGH GEOFF | Director | A Award deriv | 2024-03-27 | 2024-03-28 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Holles Natalie C. | CEO | A Award deriv | 2024-01-05 | 2024-01-05 | 396,000 | — | $0 | 396,000 | SEC↗ |
| Murphy Christopher M. | Chief Financial & Bus. Offic | A Award deriv | 2024-01-05 | 2024-01-09 | 410,000 | — | $0 | 410,000 | SEC↗ |
| Conner Edward R. | Chief Medical Officer | A Award deriv | 2024-01-05 | 2024-01-09 | 133,000 | — | $0 | 133,000 | SEC↗ |
| Person Julie | Chief Administrative Officer | A Award deriv | 2024-01-05 | 2024-01-09 | 116,000 | — | $0 | 116,000 | SEC↗ |
| Holles Natalie C. | CEO | A Award deriv | 2024-01-05 | 2024-01-09 | 396,000 | — | $0 | 396,000 | SEC↗ |
| Conner Edward R. | Chief Medical Officer | M Exercise deriv | 2023-12-05 | 2023-12-07 | 4,790 | — | $0 | 378,498 | SEC↗ |
| Person Julie | Chief Administrative Officer | M Exercise deriv | 2023-12-05 | 2023-12-07 | 12,863 | — | $0 | 67,137 | SEC↗ |
| Conner Edward R. | Chief Medical Officer | M Exercise | 2023-12-05 | 2023-12-07 | 4,790 | $4.20 | $20.1K | 4,790 | SEC↗ |
| Conner Edward R. | Chief Medical Officer | S Sale | 2023-12-05 | 2023-12-07 | 4,790 | $10.03 | $48.0K | 0 | SEC↗ |
| Person Julie | Chief Administrative Officer | S Sale | 2023-12-05 | 2023-12-07 | 12,863 | $10.30 | $132.5K | 0 | SEC↗ |
| Person Julie | Chief Administrative Officer | M Exercise | 2023-12-05 | 2023-12-07 | 12,863 | $4.20 | $54.0K | 12,863 | SEC↗ |
| Bonita David P | Director, 10% Owner | A Award deriv | 2023-06-06 | 2023-06-08 | 16,250 | — | $0 | 16,250 | SEC↗ |
| Gladstone Michael | Director | A Award deriv | 2023-06-06 | 2023-06-08 | 16,250 | — | $0 | 16,250 | SEC↗ |
| Iwicki Mark T | Director | A Award deriv | 2023-06-06 | 2023-06-08 | 16,250 | — | $0 | 16,250 | SEC↗ |
| Seidel Hans Martin | Director | A Award deriv | 2023-06-06 | 2023-06-08 | 16,250 | — | $0 | 16,250 | SEC↗ |
| Soloway Thomas P | Director | A Award deriv | 2023-06-06 | 2023-06-08 | 16,250 | — | $0 | 16,250 | SEC↗ |
| Ray Adrian S. | Chief Scientific Officer | D To issuer deriv | 2023-03-06 | 2023-03-08 | 95,000 | — | $0 | 0 | SEC↗ |
| Ray Adrian S. | Chief Scientific Officer | A Award deriv | 2023-03-06 | 2023-03-08 | 309,871 | — | $0 | 309,871 | SEC↗ |
| Ray Adrian S. | Chief Scientific Officer | D To issuer deriv | 2023-03-06 | 2023-03-08 | 309,871 | — | $0 | 0 | SEC↗ |
| Ray Adrian S. | Chief Scientific Officer | A Award deriv | 2023-03-06 | 2023-03-08 | 132,000 | — | $0 | 132,000 | SEC↗ |
| Ray Adrian S. | Chief Scientific Officer | A Award deriv | 2023-03-06 | 2023-03-08 | 95,000 | — | $0 | 95,000 | SEC↗ |
| Ho Robert | Chief Financial Officer | A Award deriv | 2023-03-06 | 2023-03-08 | 95,000 | — | $0 | 95,000 | SEC↗ |
| Ho Robert | Chief Financial Officer | D To issuer deriv | 2023-03-06 | 2023-03-08 | 367,955 | — | $0 | 0 | SEC↗ |
| Ho Robert | Chief Financial Officer | A Award deriv | 2023-03-06 | 2023-03-08 | 367,955 | — | $0 | 367,955 | SEC↗ |
| Ho Robert | Chief Financial Officer | D To issuer deriv | 2023-03-06 | 2023-03-08 | 95,000 | — | $0 | 0 | SEC↗ |
| Ho Robert | Chief Financial Officer | A Award deriv | 2023-03-06 | 2023-03-08 | 136,000 | — | $0 | 136,000 | SEC↗ |
| Bonita David P | Director, 10% Owner | D To issuer deriv | 2023-03-06 | 2023-03-08 | 13,667 | — | $0 | 0 | SEC↗ |
| Bonita David P | Director, 10% Owner | A Award deriv | 2023-03-06 | 2023-03-08 | 13,667 | — | $0 | 13,667 | SEC↗ |
| Conner Edward R. | Chief Medical Officer | D To issuer deriv | 2023-03-06 | 2023-03-08 | 95,000 | — | $0 | 0 | SEC↗ |
| Conner Edward R. | Chief Medical Officer | A Award deriv | 2023-03-06 | 2023-03-08 | 137,000 | — | $0 | 137,000 | SEC↗ |
| Conner Edward R. | Chief Medical Officer | D To issuer deriv | 2023-03-06 | 2023-03-08 | 383,288 | — | $0 | 0 | SEC↗ |
| Conner Edward R. | Chief Medical Officer | A Award deriv | 2023-03-06 | 2023-03-08 | 383,288 | — | $0 | 383,288 | SEC↗ |
| Conner Edward R. | Chief Medical Officer | A Award deriv | 2023-03-06 | 2023-03-08 | 95,000 | — | $0 | 95,000 | SEC↗ |
| Person Julie | Chief Administrative Officer | A Award deriv | 2023-03-06 | 2023-03-08 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Person Julie | Chief Administrative Officer | A Award deriv | 2023-03-06 | 2023-03-08 | 177,069 | — | $0 | 177,069 | SEC↗ |
| Person Julie | Chief Administrative Officer | A Award deriv | 2023-03-06 | 2023-03-08 | 119,000 | — | $0 | 119,000 | SEC↗ |
| Person Julie | Chief Administrative Officer | D To issuer deriv | 2023-03-06 | 2023-03-08 | 177,069 | — | $0 | 0 | SEC↗ |
| Person Julie | Chief Administrative Officer | D To issuer deriv | 2023-03-06 | 2023-03-08 | 80,000 | — | $0 | 0 | SEC↗ |
| Iwicki Mark T | Director | D To issuer deriv | 2023-03-06 | 2023-03-08 | 13,667 | — | $0 | 0 | SEC↗ |
| Iwicki Mark T | Director | D To issuer deriv | 2023-03-06 | 2023-03-08 | 35,413 | — | $0 | 0 | SEC↗ |
| Iwicki Mark T | Director | A Award deriv | 2023-03-06 | 2023-03-08 | 13,667 | — | $0 | 13,667 | SEC↗ |
| Iwicki Mark T | Director | A Award deriv | 2023-03-06 | 2023-03-08 | 35,413 | — | $0 | 35,413 | SEC↗ |
| Seidel Hans Martin | Director | D To issuer deriv | 2023-03-06 | 2023-03-08 | 13,667 | — | $0 | 0 | SEC↗ |
| Seidel Hans Martin | Director | D To issuer deriv | 2023-03-06 | 2023-03-08 | 6,640 | — | $0 | 0 | SEC↗ |
| Seidel Hans Martin | Director | A Award deriv | 2023-03-06 | 2023-03-08 | 13,667 | — | $0 | 13,667 | SEC↗ |
| Seidel Hans Martin | Director | A Award deriv | 2023-03-06 | 2023-03-08 | 6,640 | — | $0 | 6,640 | SEC↗ |
| Gladstone Michael | Director | D To issuer deriv | 2023-03-06 | 2023-03-08 | 13,667 | — | $0 | 0 | SEC↗ |
| Gladstone Michael | Director | A Award deriv | 2023-03-06 | 2023-03-08 | 13,667 | — | $0 | 13,667 | SEC↗ |
| Holles Natalie C. | CEO | A Award deriv | 2023-03-06 | 2023-03-08 | 360,000 | — | $0 | 360,000 | SEC↗ |
| Holles Natalie C. | CEO | D To issuer deriv | 2023-03-06 | 2023-03-08 | 467,634 | — | $0 | 0 | SEC↗ |
| Holles Natalie C. | CEO | A Award deriv | 2023-03-06 | 2023-03-08 | 467,634 | — | $0 | 467,634 | SEC↗ |
| Holles Natalie C. | CEO | D To issuer deriv | 2023-03-06 | 2023-03-08 | 205,000 | — | $0 | 0 | SEC↗ |
| Holles Natalie C. | CEO | A Award deriv | 2023-03-06 | 2023-03-08 | 205,000 | — | $0 | 205,000 | SEC↗ |
| PEREZ ROBERT J | Director | A Award deriv | 2023-03-06 | 2023-03-08 | 13,667 | — | $0 | 13,667 | SEC↗ |
| PEREZ ROBERT J | Director | D To issuer deriv | 2023-03-06 | 2023-03-08 | 13,667 | — | $0 | 0 | SEC↗ |
| Soloway Thomas P | Director | A Award deriv | 2023-03-06 | 2023-03-08 | 76,582 | — | $0 | 76,582 | SEC↗ |
| Soloway Thomas P | Director | D To issuer deriv | 2023-03-06 | 2023-03-08 | 13,667 | — | $0 | 0 | SEC↗ |
| Soloway Thomas P | Director | A Award deriv | 2023-03-06 | 2023-03-08 | 13,667 | — | $0 | 13,667 | SEC↗ |
| Soloway Thomas P | Director | D To issuer deriv | 2023-03-06 | 2023-03-08 | 76,582 | — | $0 | 0 | SEC↗ |
| BIOTECHNOLOGY VALUE FUND II LP | Other | P Buy | 2022-12-20 | 2022-12-22 | 116,635 | $4.11 | $479.4K | 2,332,638 | SEC↗ |
| BIOTECHNOLOGY VALUE FUND II LP | Other | P Buy | 2022-12-20 | 2022-12-22 | 87,831 | $4.11 | $361.0K | 1,764,220 | SEC↗ |
| BIOTECHNOLOGY VALUE FUND II LP | Other | P Buy | 2022-12-20 | 2022-12-22 | 9,597 | $4.11 | $39.4K | 241,309 | SEC↗ |
| Bonita David P | Director, 10% Owner | A Award deriv | 2022-10-26 | 2022-10-27 | 13,667 | — | $0 | 13,667 | SEC↗ |
| Gladstone Michael | Director | A Award deriv | 2022-10-26 | 2022-10-27 | 13,667 | — | $0 | 13,667 | SEC↗ |
| Iwicki Mark T | Director | A Award deriv | 2022-10-26 | 2022-10-27 | 13,667 | — | $0 | 13,667 | SEC↗ |
| Lin Shao-Lee | Director | A Award deriv | 2022-10-26 | 2022-10-27 | 13,667 | — | $0 | 13,667 | SEC↗ |
| PEREZ ROBERT J | Director | A Award deriv | 2022-10-26 | 2022-10-27 | 13,667 | — | $0 | 13,667 | SEC↗ |
| Seidel Hans Martin | Director | A Award deriv | 2022-10-26 | 2022-10-27 | 13,667 | — | $0 | 13,667 | SEC↗ |
| Soloway Thomas P | Director | A Award deriv | 2022-10-26 | 2022-10-27 | 13,667 | — | $0 | 13,667 | SEC↗ |
| Conner Edward R. | Chief Medical Officer | A Award deriv | 2022-10-25 | 2022-10-27 | 95,000 | — | $0 | 95,000 | SEC↗ |
| Ho Robert | Chief Financial Officer | A Award deriv | 2022-10-25 | 2022-10-27 | 95,000 | — | $0 | 95,000 | SEC↗ |
| Holles Natalie C. | CEO | A Award deriv | 2022-10-25 | 2022-10-27 | 205,000 | — | $0 | 205,000 | SEC↗ |
| Person Julie | Chief Administrative Officer | A Award deriv | 2022-10-25 | 2022-10-27 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Ray Adrian S. | Chief Scientific Officer | A Award deriv | 2022-10-25 | 2022-10-27 | 95,000 | — | $0 | 95,000 | SEC↗ |
| Ray Adrian S. | Chief Scientific Officer | A Award deriv | 2022-10-25 | 2022-10-27 | 95,000 | — | $0 | 95,000 | SEC↗ |
| Atlas Venture Associates XI, L | 10% Owner | C Conversion deriv | 2022-09-19 | 2022-09-19 | 2,282,537 | — | $0 | 0 | SEC↗ |
| Atlas Venture Associates XI, L | 10% Owner | C Conversion deriv | 2022-09-19 | 2022-09-19 | 648,447 | — | $0 | 0 | SEC↗ |
| Atlas Venture Associates XI, L | 10% Owner | C Conversion deriv | 2022-09-19 | 2022-09-19 | 594,096 | — | $0 | 0 | SEC↗ |
| Atlas Venture Associates XI, L | 10% Owner | C Conversion deriv | 2022-09-19 | 2022-09-19 | 3,541,390 | — | $0 | 0 | SEC↗ |
| Bonita David P | Director, 10% Owner | C Conversion deriv | 2022-09-19 | 2022-09-21 | 8,593,750 | — | $0 | 0 | SEC↗ |
| Bonita David P | Director, 10% Owner | C Conversion deriv | 2022-09-19 | 2022-09-21 | 1,342,065 | — | $0 | 0 | SEC↗ |
| Bonita David P | Director, 10% Owner | C Conversion deriv | 2022-09-19 | 2022-09-21 | 2,441,407 | — | $0 | 0 | SEC↗ |
| OrbiMed Capital GP VII LLC | Director, 10% Owner | C Conversion deriv | 2022-09-19 | 2022-09-21 | 1,342,065 | — | $0 | 0 | SEC↗ |
| OrbiMed Capital GP VII LLC | Director, 10% Owner | C Conversion deriv | 2022-09-19 | 2022-09-21 | 8,593,750 | — | $0 | 0 | SEC↗ |
| OrbiMed Capital GP VII LLC | Director, 10% Owner | C Conversion deriv | 2022-09-19 | 2022-09-21 | 2,441,407 | — | $0 | 0 | SEC↗ |
| Atlas Venture Associates XI, L | 10% Owner | P Buy | 2022-09-19 | 2022-09-19 | 300,000 | $17.00 | $5.10M | 10,313,763 | SEC↗ |
| Atlas Venture Associates XI, L | 10% Owner | C Conversion | 2022-09-19 | 2022-09-19 | 6,472,374 | — | $0 | 10,013,763 | SEC↗ |
| Atlas Venture Associates XI, L | 10% Owner | C Conversion | 2022-09-19 | 2022-09-19 | 594,096 | — | $0 | 594,096 | SEC↗ |
| Bonita David P | Director, 10% Owner | C Conversion | 2022-09-19 | 2022-09-21 | 5,479,071 | — | $0 | 5,479,071 | SEC↗ |
| Bonita David P | Director, 10% Owner | P Buy | 2022-09-19 | 2022-09-21 | 300,000 | $17.00 | $5.10M | 5,779,071 | SEC↗ |
| OrbiMed Capital GP VII LLC | Director, 10% Owner | C Conversion | 2022-09-19 | 2022-09-21 | 5,479,071 | — | $0 | 5,479,071 | SEC↗ |
| OrbiMed Capital GP VII LLC | Director, 10% Owner | P Buy | 2022-09-19 | 2022-09-21 | 300,000 | $17.00 | $5.10M | 5,779,071 | SEC↗ |
| STEWART DENNIS ROBERT | EVP/CFO | M Exercise | 2014-09-16 | 2014-09-18 | 4,130 | $24.21 | $100.0K | 18,112 | SEC↗ |
| LUFKIN KENT C | President and CEO | M Exercise | 2014-09-11 | 2014-09-12 | 7,875 | $26.90 | $211.8K | 40,922 | SEC↗ |
| LUFKIN KENT C | President and CEO | M Exercise | 2014-09-11 | 2014-09-12 | 4,130 | $24.21 | $100.0K | 33,047 | SEC↗ |
| TANTALA ALBERT M | Director | A Award | 2014-04-01 | 2014-04-03 | 97 | $30.91 | $3.0K | 82,703 | SEC↗ |
| DUSEK ROBERT N | Director | A Award | 2014-04-01 | 2014-04-03 | 530 | $30.91 | $16.4K | 83,472 | SEC↗ |
| GREGORY CARL F | Director | A Award | 2014-04-01 | 2014-04-03 | 97 | $30.91 | $3.0K | 108,512 | SEC↗ |
| POLLACK DENNIS | Director | A Award | 2014-04-01 | 2014-04-03 | 97 | $30.91 | $3.0K | 9,905 | SEC↗ |
| SWANSTROM KENNETH A | Director | A Award | 2014-04-01 | 2014-04-03 | 97 | $30.91 | $3.0K | 9,339 | SEC↗ |
| KASPERN ELIZABETH A | EVP | A Award deriv | 2014-01-24 | 2014-01-31 | 3,000 | — | $0 | 3,000 | SEC↗ |
| DUSEK ROBERT N | Director | A Award | 2014-01-02 | 2014-01-06 | 581 | $28.18 | $16.4K | 82,942 | SEC↗ |
| GREGORY CARL F | Director | A Award | 2014-01-02 | 2014-01-06 | 106 | $28.18 | $3.0K | 108,415 | SEC↗ |
| POLLACK DENNIS | Director | A Award | 2014-01-02 | 2014-01-06 | 106 | $28.18 | $3.0K | 9,808 | SEC↗ |
| SWANSTROM KENNETH A | Director | A Award | 2014-01-02 | 2014-01-06 | 106 | $28.18 | $3.0K | 9,242 | SEC↗ |
| TANTALA ALBERT M | Director | A Award | 2014-01-02 | 2014-01-06 | 106 | $28.18 | $3.0K | 82,275 | SEC↗ |
| DUSEK ROBERT N | Director | A Award | 2013-10-01 | 2013-10-03 | 588 | $27.88 | $16.4K | 82,361 | SEC↗ |
| GREGORY CARL F | Director | A Award | 2013-10-01 | 2013-10-03 | 107 | $27.88 | $3.0K | 108,309 | SEC↗ |
| POLLACK DENNIS | Director | A Award | 2013-10-01 | 2013-10-03 | 107 | $27.88 | $3.0K | 9,683 | SEC↗ |
| Slabinski Joseph F III | Director | A Award | 2013-10-01 | 2013-10-03 | 107 | $27.88 | $3.0K | 19,098 | SEC↗ |
| SWANSTROM KENNETH A | Director | A Award | 2013-10-01 | 2013-10-03 | 107 | $27.88 | $3.0K | 9,136 | SEC↗ |
| TANTALA ALBERT M | Director | A Award | 2013-10-01 | 2013-10-03 | 107 | $27.88 | $3.0K | 81,875 | SEC↗ |
| Wood James B | Director | A Award | 2013-10-01 | 2013-10-03 | 107 | $27.88 | $3.0K | 6,511 | SEC↗ |
| PERKINS H DONALD JR | Director | A Award | 2013-10-01 | 2013-10-03 | 107 | $27.88 | $3.0K | 5,304 | SEC↗ |
| DUSEK ROBERT N | Director | P Buy | 2013-09-30 | 2013-10-01 | 1,055 | $27.55 | $29.1K | 81,773 | SEC↗ |
| DUSEK ROBERT N | Director | P Buy | 2013-09-25 | 2013-09-27 | 100 | $26.80 | $2.7K | 80,718 | SEC↗ |
| DUSEK ROBERT N | Other | P Buy | 2013-09-19 | 2013-09-23 | 240 | $26.86 | $6.4K | 80,618 | SEC↗ |
| POLLACK DENNIS | Director | P Buy | 2013-09-12 | 2013-09-16 | 197 | $26.80 | $5.3K | 9,576 | SEC↗ |
| TANTALA ALBERT M | Director | P Buy | 2013-08-15 | 2013-08-19 | 286 | $31.98 | $9.1K | 81,768 | SEC↗ |
| TANTALA ALBERT M | Director | P Buy | 2013-08-15 | 2013-08-19 | 461 | $31.98 | $14.7K | 57,814 | SEC↗ |
| DUSEK ROBERT N | Other | P Buy | 2013-08-01 | 2013-08-01 | 2 | $27.00 | $54 | 7,470 | SEC↗ |
| DUSEK ROBERT N | Other | P Buy | 2013-08-01 | 2013-08-01 | 198 | $27.50 | $5.4K | 7,668 | SEC↗ |
| LUFKIN KENT C | President and CEO | A Award deriv | 2013-07-30 | 2013-08-01 | 5,000 | — | $0 | 5,000 | SEC↗ |
| DUSEK ROBERT N | Other | P Buy | 2013-07-30 | 2013-08-01 | 870 | $27.00 | $23.5K | 7,468 | SEC↗ |
| Slabinski Joseph F III | Director | F Tax w/h | 2013-07-26 | 2013-07-29 | 7,807 | $25.94 | $202.5K | 18,991 | SEC↗ |
| Slabinski Joseph F III | Director | M Exercise | 2013-07-26 | 2013-07-29 | 7,875 | $25.71 | $202.5K | 26,798 | SEC↗ |
| TANTALA ALBERT M | Director | A Award | 2013-07-01 | 2013-07-03 | 118 | $25.40 | $3.0K | 81,482 | SEC↗ |
| POLLACK DENNIS | Director | A Award | 2013-07-01 | 2013-07-03 | 118 | $25.40 | $3.0K | 9,379 | SEC↗ |
| PERKINS H DONALD JR | Director | A Award | 2013-07-01 | 2013-07-03 | 118 | $25.40 | $3.0K | 5,197 | SEC↗ |
| DUSEK ROBERT N | Other | A Award | 2013-07-01 | 2013-07-03 | 645 | $25.40 | $16.4K | 80,378 | SEC↗ |
| GREGORY CARL F | Director | A Award | 2013-07-01 | 2013-07-03 | 118 | $25.40 | $3.0K | 108,202 | SEC↗ |
| SWANSTROM KENNETH A | Director | A Award | 2013-07-01 | 2013-07-03 | 118 | $25.40 | $3.0K | 9,029 | SEC↗ |
| Wood James B | Director | A Award | 2013-07-01 | 2013-07-03 | 118 | $25.40 | $3.0K | 6,404 | SEC↗ |
| Slabinski Joseph F III | Director | A Award | 2013-07-01 | 2013-07-03 | 118 | $25.40 | $3.0K | 18,923 | SEC↗ |
| PERKINS H DONALD JR | Director | P Buy | 2013-05-01 | 2013-05-01 | 2,000 | $25.20 | $50.4K | 5,000 | SEC↗ |
| PERKINS H DONALD JR | Director | A Award | 2013-05-01 | 2013-05-03 | 79 | $25.14 | $2.0K | 5,079 | SEC↗ |
| PERKINS H DONALD JR | Director | P Buy | 2013-04-30 | 2013-05-01 | 1,500 | $25.20 | $37.8K | 3,000 | SEC↗ |
| PERKINS H DONALD JR | Director | P Buy | 2013-04-29 | 2013-05-01 | 500 | $25.11 | $12.6K | 1,500 | SEC↗ |
| POLLACK DENNIS | Director | A Award | 2013-04-01 | 2013-04-03 | 123 | $24.27 | $3.0K | 9,261 | SEC↗ |
| TANTALA ALBERT M | Director | A Award | 2013-04-01 | 2013-04-03 | 123 | $24.27 | $3.0K | 81,203 | SEC↗ |
| DUSEK ROBERT N | Other | A Award | 2013-04-01 | 2013-04-03 | 675 | $24.27 | $16.4K | 79,733 | SEC↗ |
| GREGORY CARL F | Director | A Award | 2013-04-01 | 2013-04-03 | 123 | $24.27 | $3.0K | 108,084 | SEC↗ |
| SWANSTROM KENNETH A | Director | A Award | 2013-04-01 | 2013-04-03 | 123 | $24.27 | $3.0K | 8,911 | SEC↗ |
| Wood James B | Director | A Award | 2013-04-01 | 2013-04-03 | 123 | $24.27 | $3.0K | 6,286 | SEC↗ |
| Slabinski Joseph F III | Director | A Award | 2013-04-01 | 2013-04-03 | 123 | $24.27 | $3.0K | 18,805 | SEC↗ |
| PERKINS H DONALD JR | Director | P Buy | 2013-03-13 | 2013-03-15 | 500 | $24.75 | $12.4K | 1,000 | SEC↗ |
| PERKINS H DONALD JR | Director | P Buy | 2013-03-08 | 2013-03-12 | 500 | $25.00 | $12.5K | 500 | SEC↗ |
| POLLACK DENNIS | Director | P Buy | 2013-02-25 | 2013-02-27 | 500 | $25.50 | $12.8K | 9,138 | SEC↗ |
| TANTALA ALBERT M | Director | P Buy | 2013-02-15 | 2013-02-20 | 198 | $25.44 | $5.0K | 81,080 | SEC↗ |
| TANTALA ALBERT M | Director | P Buy | 2013-02-15 | 2013-02-20 | 465 | $25.44 | $11.8K | 57,240 | SEC↗ |
| POLLACK DENNIS | Director | P Buy | 2013-01-30 | 2013-01-31 | 298 | $24.25 | $7.2K | 8,638 | SEC↗ |
| POLLACK DENNIS | Director | P Buy | 2013-01-29 | 2013-01-31 | 202 | $24.25 | $4.9K | 8,340 | SEC↗ |
| TANTALA ALBERT M | Director | A Award deriv | 2013-01-23 | 2014-04-03 | 15,000 | — | $0 | 15,000 | SEC↗ |
| DUSEK ROBERT N | Director | A Award deriv | 2013-01-23 | 2014-04-03 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GREGORY CARL F | Director | A Award deriv | 2013-01-23 | 2014-04-03 | 10,000 | — | $0 | 10,000 | SEC↗ |
| POLLACK DENNIS | Director | A Award deriv | 2013-01-23 | 2014-04-03 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SWANSTROM KENNETH A | Director | A Award deriv | 2013-01-23 | 2014-04-03 | 10,000 | — | $0 | 10,000 | SEC↗ |
| DUSEK ROBERT N | Director | A Award deriv | 2013-01-23 | 2014-01-06 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GREGORY CARL F | Director | A Award deriv | 2013-01-23 | 2014-01-06 | 10,000 | — | $0 | 10,000 | SEC↗ |
| POLLACK DENNIS | Director | A Award deriv | 2013-01-23 | 2014-01-06 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SWANSTROM KENNETH A | Director | A Award deriv | 2013-01-23 | 2014-01-06 | 10,000 | — | $0 | 10,000 | SEC↗ |
| TANTALA ALBERT M | Director | A Award deriv | 2013-01-23 | 2014-01-06 | 15,000 | — | $0 | 15,000 | SEC↗ |
| DUSEK ROBERT N | Director | A Award deriv | 2013-01-23 | 2013-10-01 | 15,000 | — | $0 | 15,000 | SEC↗ |
| DUSEK ROBERT N | Director | A Award deriv | 2013-01-23 | 2013-10-03 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GREGORY CARL F | Director | A Award deriv | 2013-01-23 | 2013-10-03 | 10,000 | — | $0 | 10,000 | SEC↗ |
| POLLACK DENNIS | Director | A Award deriv | 2013-01-23 | 2013-10-03 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Slabinski Joseph F III | Director | A Award deriv | 2013-01-23 | 2013-10-03 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SWANSTROM KENNETH A | Director | A Award deriv | 2013-01-23 | 2013-10-03 | 10,000 | — | $0 | 10,000 | SEC↗ |
| TANTALA ALBERT M | Director | A Award deriv | 2013-01-23 | 2013-10-03 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Wood James B | Director | A Award deriv | 2013-01-23 | 2013-10-03 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PERKINS H DONALD JR | Director | A Award deriv | 2013-01-23 | 2013-10-03 | 10,000 | — | $0 | 10,000 | SEC↗ |
| TANTALA ALBERT M | Director | A Award deriv | 2013-01-23 | 2013-07-03 | 15,000 | — | $0 | 15,000 | SEC↗ |
| POLLACK DENNIS | Director | A Award deriv | 2013-01-23 | 2013-07-03 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PERKINS H DONALD JR | Director | A Award deriv | 2013-01-23 | 2013-07-03 | 10,000 | — | $0 | 10,000 | SEC↗ |
| DUSEK ROBERT N | Other | A Award deriv | 2013-01-23 | 2013-07-03 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GREGORY CARL F | Director | A Award deriv | 2013-01-23 | 2013-07-03 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SWANSTROM KENNETH A | Director | A Award deriv | 2013-01-23 | 2013-07-03 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Wood James B | Director | A Award deriv | 2013-01-23 | 2013-07-03 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Slabinski Joseph F III | Director | A Award deriv | 2013-01-23 | 2013-07-03 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Slabinski Joseph F III | Director | A Award deriv | 2013-01-23 | 2013-07-29 | 10,000 | — | $0 | 10,000 | SEC↗ |
| DUSEK ROBERT N | Other | A Award deriv | 2013-01-23 | 2013-08-01 | 15,000 | — | $0 | 15,000 | SEC↗ |
| TANTALA ALBERT M | Director | A Award deriv | 2013-01-23 | 2013-08-19 | 15,000 | — | $0 | 15,000 | SEC↗ |
| POLLACK DENNIS | Director | A Award deriv | 2013-01-23 | 2013-09-16 | 10,000 | — | $0 | 10,000 | SEC↗ |
| DUSEK ROBERT N | Other | A Award deriv | 2013-01-23 | 2013-09-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| DUSEK ROBERT N | Director | A Award deriv | 2013-01-23 | 2013-09-27 | 15,000 | — | $0 | 15,000 | SEC↗ |
| POLLACK DENNIS | Director | A Award deriv | 2013-01-23 | 2013-04-03 | 10,000 | — | $0 | 10,000 | SEC↗ |
| TANTALA ALBERT M | Director | A Award deriv | 2013-01-23 | 2013-04-03 | 15,000 | — | $0 | 15,000 | SEC↗ |
| DUSEK ROBERT N | Other | A Award deriv | 2013-01-23 | 2013-04-03 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GREGORY CARL F | Director | A Award deriv | 2013-01-23 | 2013-04-03 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SWANSTROM KENNETH A | Director | A Award deriv | 2013-01-23 | 2013-04-03 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Wood James B | Director | A Award deriv | 2013-01-23 | 2013-04-03 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Slabinski Joseph F III | Director | A Award deriv | 2013-01-23 | 2013-04-03 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PERKINS H DONALD JR | Director | A Award deriv | 2013-01-23 | 2013-05-01 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PERKINS H DONALD JR | Director | A Award deriv | 2013-01-23 | 2013-05-01 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PERKINS H DONALD JR | Director | A Award deriv | 2013-01-23 | 2013-05-03 | 10,000 | — | $0 | 10,000 | SEC↗ |
| TANTALA ALBERT M | Director | A Award deriv | 2013-01-23 | 2013-01-25 | 15,000 | — | $0 | 15,000 | SEC↗ |
| POLLACK DENNIS | Director | A Award deriv | 2013-01-23 | 2013-01-25 | 10,000 | — | $0 | 10,000 | SEC↗ |
| DUSEK ROBERT N | Other | A Award deriv | 2013-01-23 | 2013-01-25 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GREGORY CARL F | Director | A Award deriv | 2013-01-23 | 2013-01-25 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SWANSTROM KENNETH A | Director | A Award deriv | 2013-01-23 | 2013-01-25 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Wood James B | Director | A Award deriv | 2013-01-23 | 2013-01-25 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Slabinski Joseph F III | Director | A Award deriv | 2013-01-23 | 2013-01-25 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PERKINS H DONALD JR | Director | A Award deriv | 2013-01-23 | 2013-01-25 | 10,000 | — | $0 | 10,000 | SEC↗ |
| STEWART DENNIS ROBERT | EVP/CFO | A Award deriv | 2013-01-23 | 2013-01-25 | 13,500 | — | $0 | 13,500 | SEC↗ |
| STEWART DENNIS ROBERT | EVP/CFO | A Award deriv | 2013-01-23 | 2013-01-25 | 13,500 | — | $0 | 13,500 | SEC↗ |
| LUFKIN KENT C | President and CEO | A Award deriv | 2013-01-23 | 2013-01-25 | 50,000 | — | $0 | 50,000 | SEC↗ |
| KASPERN ELIZABETH A | EVP | A Award deriv | 2013-01-23 | 2013-01-25 | 13,500 | — | $0 | 13,500 | SEC↗ |
| POLLACK DENNIS | Director | A Award deriv | 2013-01-23 | 2013-01-31 | 10,000 | — | $0 | 10,000 | SEC↗ |
| TANTALA ALBERT M | Director | A Award deriv | 2013-01-23 | 2013-02-20 | 15,000 | — | $0 | 15,000 | SEC↗ |
| POLLACK DENNIS | Director | A Award deriv | 2013-01-23 | 2013-02-27 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PERKINS H DONALD JR | Director | A Award deriv | 2013-01-23 | 2013-03-12 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PERKINS H DONALD JR | Director | A Award deriv | 2013-01-23 | 2013-03-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| TANTALA ALBERT M | Director | A Award | 2013-01-02 | 2013-01-04 | 125 | $23.82 | $3.0K | 80,882 | SEC↗ |
| Slabinski Joseph F III | Director | A Award | 2013-01-02 | 2013-01-04 | 125 | $23.82 | $3.0K | 18,682 | SEC↗ |
| POLLACK DENNIS | Director | A Award | 2013-01-02 | 2013-01-04 | 125 | $23.82 | $3.0K | 8,138 | SEC↗ |
| DUSEK ROBERT N | Other | A Award | 2013-01-02 | 2013-01-04 | 688 | $23.82 | $16.4K | 79,058 | SEC↗ |
| GREGORY CARL F | Director | A Award | 2013-01-02 | 2013-01-04 | 125 | $23.82 | $3.0K | 107,961 | SEC↗ |
| SWANSTROM KENNETH A | Director | A Award | 2013-01-02 | 2013-01-04 | 125 | $23.82 | $3.0K | 8,788 | SEC↗ |
| Wood James B | Director | A Award | 2013-01-02 | 2013-01-04 | 125 | $23.82 | $3.0K | 6,163 | SEC↗ |
| TANTALA ALBERT M | Director | A Award | 2012-10-01 | 2012-10-03 | 124 | $24.14 | $3.0K | 80,580 | SEC↗ |
| STRANFORD JOHN R | Director | A Award | 2012-10-01 | 2012-10-03 | 124 | $24.14 | $3.0K | 79,036 | SEC↗ |